LOCUS       NP_000785                446 aa                     PRI 11-MAY-2014
DEFINITION  D(1A) dopamine receptor [Homo sapiens].
ACCESSION   NP_000785
VERSION     NP_000785.1  GI:4503383
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 446)
  AUTHORS   Fresnoza S, Paulus W, Nitsche MA and Kuo MF.
  TITLE     Nonlinear dose-dependent impact of D1 receptor activation on motor
            cortex plasticity in humans
  JOURNAL   J. Neurosci. 34 (7), 2744-2753 (2014)
   PUBMED   24523562
  REMARK    GeneRIF: These data extend findings of dose-dependent inverted
            U-shaped effects of D1 receptor activation on neuroplasticity of the
            motor cortex.
REFERENCE   2  (residues 1 to 446)
  AUTHORS   Sidharthan NP, Minchin RF and Butcher NJ.
  TITLE     Cytosolic sulfotransferase 1A3 is induced by dopamine and protects
            neuronal cells from dopamine toxicity: role of D1
            receptor-N-methyl-D-aspartate receptor coupling
  JOURNAL   J. Biol. Chem. 288 (48), 34364-34374 (2013)
   PUBMED   24136195
  REMARK    GeneRIF: we show that SULT1A3 and a closely related protein SULT1A1
            are highly inducible by dopamine. This involves activation of the D1
            and NMDA receptors. Both ERK1/2 phosphorylation and calcineurin
            activation are required for induction.
REFERENCE   3  (residues 1 to 446)
  AUTHORS   Jacobs,M.M., Murray,J., Byrd,D.A., Hurd,Y.L. and Morgello,S.
  TITLE     HIV-related cognitive impairment shows bi-directional association
            with dopamine receptor DRD1 and DRD2 polymorphisms in
            substance-dependent and substance-independent populations
  JOURNAL   J. Neurovirol. 19 (5), 495-504 (2013)
   PUBMED   24078558
  REMARK    GeneRIF: HIV-related cognitive impairment shows bi-directional
            association with dopamine receptor DRD1 and DRD2 polymorphisms in
            substance-dependent and substance-independent populations.
REFERENCE   4  (residues 1 to 446)
  AUTHORS   Zhu F, Yan CX, Wen YC, Wang J, Bi J, Zhao YL, Wei L, Gao CG, Jia W
            and Li SB.
  TITLE     Dopamine D1 receptor gene variation modulates opioid dependence risk
            by affecting transition to addiction
  JOURNAL   PLoS ONE 8 (8), E70805 (2013)
   PUBMED   23976958
  REMARK    GeneRIF: DRD1 rs686 minor allele decreases the opioid dependence
            risk by prolonging the transition to dependence and attenuating
            opioid-induced pleasure in the Chinese. Publication Status:
            Online-Only
REFERENCE   5  (residues 1 to 446)
  AUTHORS   Levy,F., Wimalaweera,S., Moul,C., Brennan,J. and Dadds,M.R.
  TITLE     Dopamine receptors and the pharmacogenetics of side-effects of
            stimulant treatment for attention-deficit/hyperactivity disorder
  JOURNAL   J Child Adolesc Psychopharmacol 23 (6), 423-425 (2013)
   PUBMED   23952191
  REMARK    GeneRIF: D1 allelic status (rs4532) predicts side-effects from
            stimulant medication for attention-deficit/ hyperactivity disorder
REFERENCE   6
  AUTHORS   Lamey,M., Thompson,M., Varghese,G., Chi,H., Sawzdargo,M.,
            George,S.R. and O'Dowd,B.F.
  TITLE     Distinct residues in the carboxyl tail mediate agonist-induced
            desensitization and internalization of the human dopamine D1
            receptor
  JOURNAL   J. Biol. Chem. 277 (11), 9415-9421 (2002)
   PUBMED   11773080
REFERENCE   7
  AUTHORS   Jin,H., Xie,Z., George,S.R. and O'Dowd,B.F.
  TITLE     Palmitoylation occurs at cysteine 347 and cysteine 351 of the
            dopamine D(1) receptor
  JOURNAL   Eur. J. Pharmacol. 386 (2-3), 305-312 (1999)
   PUBMED   10618483
REFERENCE   8  (residues 1 to 446)
  AUTHORS   Liu YF, Civelli O, Zhou QY and Albert PR.
  TITLE     Cholera toxin-sensitive 3',5'-cyclic adenosine monophosphate and
            calcium signals of the human dopamine-D1 receptor: selective
            potentiation by protein kinase A
  JOURNAL   Mol. Endocrinol. 6 (11), 1815-1824 (1992)
   PUBMED   1282671
REFERENCE   9  (residues 1 to 446)
  AUTHORS   Minowa MT, Minowa T, Monsma FJ Jr, Sibley DR and Mouradian MM.
  TITLE     Characterization of the 5' flanking region of the human D1A dopamine
            receptor gene
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 89 (7), 3045-3049 (1992)
   PUBMED   1557411
  REMARK    Erratum:[Proc Natl Acad Sci U S A 1992 May 1;89(9):4220]
REFERENCE   10  (residues 1 to 446)
  AUTHORS   Tiberi M, Jarvie KR, Silvia C, Falardeau P, Gingrich JA, Godinot N,
            Bertrand L, Yang-Feng TL, Fremeau RT Jr and Caron MG.
  TITLE     Cloning, molecular characterization, and chromosomal assignment of a
            gene encoding a second D1 dopamine receptor subtype: differential
            expression pattern in rat brain compared with the D1A receptor
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 88 (17), 7491-7495 (1991)
   PUBMED   1831904
REFERENCE   11  (residues 1 to 446)
  AUTHORS   Grandy DK, Zhou QY, Allen L, Litt R, Magenis RE, Civelli O and Litt
            M.
  TITLE     A human D1 dopamine receptor gene is located on chromosome 5 at
            q35.1 and identifies an EcoRI RFLP
  JOURNAL   Am. J. Hum. Genet. 47 (5), 828-834 (1990)
   PUBMED   1977312
REFERENCE   12  (residues 1 to 446)
  AUTHORS   Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy
            JL, Gelernter JE, Rozmahel R, Yang YL and Israel Y.
  CONSRTM   et al
  TITLE     Human dopamine D1 receptor encoded by an intronless gene on
            chromosome 5
  JOURNAL   Nature 347 (6288), 80-83 (1990)
   PUBMED   1975640
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from DA249160.1, AC091393.3 and
            X58987.1.
            This sequence is a reference standard in the RefSeqGene project.
            Summary: This gene encodes the D1 subtype of the dopamine receptor.
            The D1 subtype is the most abundant dopamine receptor in the
            central nervous system. This G-protein coupled receptor stimulates
            adenylyl cyclase and activates cyclic AMP-dependent protein
            kinases. D1 receptors regulate neuronal growth and development,
            mediate some behavioral responses, and modulate dopamine receptor
            D2-mediated events. Alternate transcription initiation sites result
            in two transcript variants of this gene. [provided by RefSeq, Jul
            2008].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript exon combination :: DA249160.1, DA228014.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
            ERS025084, ERS025087 [ECO:0000348]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..446
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="5"
                     /map="5q35.1"
     Protein         1..446
                     /note="dopamine D1 receptor"
                     /product="D(1A) dopamine receptor"
                     /calculated_mol_wt="49162"
     Site            24..49
                     /note="propagated from UniProtKB/Swiss-Prot (P21728.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          41..>158
                     /note="Serpentine type 7TM GPCR chemoreceptor Srx;
                     pfam10328"
                     /db_xref="CDD:255910"
                     /region_name="7TM_GPCR_Srx"
     Region          46..331
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            61..87
                     /note="propagated from UniProtKB/Swiss-Prot (P21728.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            97..119
                     /note="propagated from UniProtKB/Swiss-Prot (P21728.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            139..163
                     /note="propagated from UniProtKB/Swiss-Prot (P21728.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            193..218
                     /note="propagated from UniProtKB/Swiss-Prot (P21728.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            273..299
                     /note="propagated from UniProtKB/Swiss-Prot (P21728.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            313..337
                     /note="propagated from UniProtKB/Swiss-Prot (P21728.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            347
                     /note="palmitoylation site"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[7]"
                     /site_type="modified"
     Site            351
                     /note="palmitoylation site"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[7]"
                     /site_type="modified"
     Site            360
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /citation="[6]"
                     /site_type="phosphorylation"
     CDS             1..446
                     /coded_by="NM_000794.3:946..2286"
                     /gene="DRD1"
                     /gene_synonym="DADR; DRD1A"
                     /db_xref="CCDS:CCDS4393.1"
                     /db_xref="GeneID:1812"
                     /db_xref="HGNC:HGNC:3020"
                     /db_xref="HPRD:00538"
                     /db_xref="MIM:126449"
ORIGIN
        1 mrtlntsamd gtglvverdf svriltacfl sllilstllg ntlvcaavir frhlrskvtn
       61 ffvislavsd llvavlvmpw kavaeiagfw pfgsfcniwv afdimcstas ilnlcvisvd
      121 rywaisspfr yerkmtpkaa filisvawtl svlisfipvq lswhkakpts psdgnatsla
      181 etidncdssl srtyaisssv isfyipvaim ivtytriyri aqkqirriaa leraavhakn
      241 cqtttgngkp vecsqpessf kmsfkretkv lktlsvimgv fvccwlpffi lncilpfcgs
      301 getqpfcids ntfdvfvwfg wansslnpii yafnadfrka fstllgcyrl cpatnnaiet
      361 vsinnngaam fsshheprgs iskecnlvyl iphavgssed lkkeeaagia rpleklspal
      421 svildydtdv slekiqpitq ngqhpt
//
